Tagged with USA

Biden’s New FDA Pick Not Without Controversy

USA Biden’s New FDA Pick Not Without Controversy

USA Almost ten months into his presidency, Joe Biden has announced his pick to lead the US Food and Drug Administration (FDA). If confirmed by the Senate, the nominee, Dr Robert Califf, would become commissioner for a second time after leading the agency for almost a year at the end of…

Melanie Croce-Galis – Director, US Patient Engagement, Oncology, Novartis

USA Melanie Croce-Galis – Director, US Patient Engagement, Oncology, Novartis

USA Melanie Croce-Galis, RN, MPH explains the specificities of her work as patient engagement lead for Novartis Oncology in the US market, where significant disparities in patient access to information and to care throw up several challenges. Croce-Galis also outlines the work being done around CAR-T therapies and why integrating and…

2021 Drug Formulary Exclusions Continue to Reduce Therapy Choice for US Consumers

USA 2021 Drug Formulary Exclusions Continue to Reduce Therapy Choice for US Consumers

USA Susan L. Lang outlines how pharma companies can navigate drug formulary exclusions, numbers of which have been rising in recent years, and ensure that newly FDA approved medicines can make it to consumers. The pipeline for new therapies at the Food and Drug Administration mostly consists of novel brand…

Navin Pinto – Attending Physician, Seattle Children’s Hospital; Associate Professor of Paediatrics, University of Washington School of Medicine

USA Navin Pinto – Attending Physician, Seattle Children’s Hospital; Associate Professor of Paediatrics, University of Washington School of Medicine

USA Paediatric oncologist Navin Pinto, MD outlines the current use and potential of CAR-T therapies in his field, including the manufacturing challenges that still need to be addressed. Dr Pinto also explains how the work of his CAR-T team at the University of Washington School of Medicine could provide proof of…

Claire Saxton – Vice President, Patient Experience & Lauren Kriegel – Helpline Community Navigator, Cancer Support Community

USA Claire Saxton – Vice President, Patient Experience & Lauren Kriegel – Helpline Community Navigator, Cancer Support Community

USA Claire Saxton and Lauren Kriegel of Cancer Support Community, the largest professionally led non-profit network of cancer support worldwide, discuss how cancer patient and caregiver perspectives need to be better integrated into the treatment process. This is an especially prescient issue for next-generation cell and gene therapies such as CAR-T…

NORD’s Breakthrough Summit: Listening to the Rare Disease Patient Voice

USA NORD’s Breakthrough Summit: Listening to the Rare Disease Patient Voice

USA The National Organization for Rare Disorders (NORD) is set to host its annual Rare Diseases and Orphan Products Breakthrough Summit on October 18-19th. Ahead of the Summit, the Chair of NORD’s Board of Directors Kay Holcombe explains its significance for cross-stakeholder interaction and learning and why we are entering “a…

PhRMA COO: Removing Protections in Medicare Would Harm Seniors

USA PhRMA COO: Removing Protections in Medicare Would Harm Seniors

USA PhRMA’s Lori Reilly warns that, as US policymakers seek to reduce drug prices, they must avoid policies that reduce access and choice. America is the centre of cutting-edge biopharmaceutical innovation. Not only are many of the latest treatments and cures developed in labs by researchers across the United States,…

Sam Volchenboum – Associate Professor of Pediatrics, Dean of Master’s Education, Associate Chief, Research Informatics Officer Associate Director, Institute for Translational Medicine, University of Chicago

USA Sam Volchenboum – Associate Professor of Pediatrics, Dean of Master’s Education, Associate Chief, Research Informatics Officer Associate Director, Institute for Translational Medicine, University of Chicago

USA Dr Sam Volchenboum outlines the progress that has been made in the paediatric oncology field in recent years and his hopes for its future. Dr Volchenboum also explains the important role that data will play in the new era of targeted and personalised therapies and the impact of the work…

Sanofi Genzyme EVP Bill Sibold Reflects on 30 Years of Rare Disease CSR Program

Global Sanofi Genzyme EVP Bill Sibold Reflects on 30 Years of Rare Disease CSR Program

Global Bill Sibold, Executive Vice President and Head of Sanofi Genzyme, highlights the achievements of the company’s Rare Humanitarian Program over the last 30 years, bringing treatments to patients in developing countries with lysomal storage disorders who would otherwise not have access. Sibold outlines the persistent obstacles facing people with rare…

USA: Drug Innovations Are Delivering for Patients; We Need Innovation In How They’re Paid For

USA USA: Drug Innovations Are Delivering for Patients; We Need Innovation In How They’re Paid For

USA John M. O’Brien, recently appointed president and CEO of the US National Pharmaceutical Council, calls for innovation in benefit design reform to match the unparalleled speed and ingenuity with which the biopharmaceutical industry developed vaccines and therapeutics to combat the COVID-19 pandemic. The biopharmaceutical industry developed COVID-19 vaccines and…

Top 2021 Insights from Global Regulators

Global Top 2021 Insights from Global Regulators

Global Over the past 12 months, PharmaBoardroom has spoken to the heads of several key regulatory bodies across the world. While the approval processes for COVID-19 vaccines have evidently been top of their priority lists, other key topics discussed included the potential of data and AI to change the drug approval…

Note to Biogen: Your Marketing is Showing

USA Note to Biogen: Your Marketing is Showing

USA In his latest PharmaBoardroom piece, John Singer looks at Biogen’s marketing campaign for its new Alzheimer’s drug, extending and linking the controversy to the grander strategic themes reshaping the ‘drug market’ as a whole, including the impact of the internet on cognitive change, the unmet need for a different premise for…

1 … 9 10 11 … 30